COVID-19 vaccine effective against hospitalization from Omicron variant
The BNT162b2 vaccine is moderately effective at preventing hospitalization from the Omicron strand of COVID-19 for 4 months after vaccination in pediatric patients aged 5 to 11 years, according to a recent study.
The COVID-19 vaccine had a 90.7% vaccine effectiveness (VE) against early strands of the virus in children, but the significant immune evasion of the Omicron variant has had a major impact on the VE. While early data indicated a VE of 31% against Omicron infection and 68% to 74% against hospitalization, there is little data on VE against Omicron after 2 months…. [read more]